PE20000887A1 - "PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROL - Google Patents

"PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROL

Info

Publication number
PE20000887A1
PE20000887A1 PE1999000799A PE00079999A PE20000887A1 PE 20000887 A1 PE20000887 A1 PE 20000887A1 PE 1999000799 A PE1999000799 A PE 1999000799A PE 00079999 A PE00079999 A PE 00079999A PE 20000887 A1 PE20000887 A1 PE 20000887A1
Authority
PE
Peru
Prior art keywords
progestagen
cycle control
good cycle
allows good
type contraceptive
Prior art date
Application number
PE1999000799A
Other languages
Spanish (es)
Inventor
Petrus Gustaaf Wilhelmus Stokman
Gerardus Herman Vitus Korver
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20000887A1 publication Critical patent/PE20000887A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN KIT ANTICONCEPTIVO QUE COMPRENDE MEDIOS PARA LA ADMINISTRACION DIARIA DE PROGESTAGENO, CARACTERIZADO POR ESTAR DIVIDIDOS EN DOS FASES: I) ADMINISTRACION DIARIA DE 10 A 20 DIAS DE UN PROGESTAGENO EN UNA CANTIDAD LO MAS BAJA POSIBLE PARA INHIBIR LA OVULACION; Y, II) ADMINISTRACION DIARIA AL MENOS DURANTE 7 DIAS DE UN PROGESTAGENO EN UNA CANTIDAD QUE ES AL MENOS EL DOBLE DE LA FASE I), PERO NO MAS BAJA QUE LA DOSIS REQUERIDA PARA CAUSAR LA TRANSFORMACION DEL ENDOMETRIO. DONDE, EL PROGESTAGENO SE SELECCIONA DEL GRUPO CONSISTENTE EN DESOGESTREL, ORG 30659, LEVONORGESTREL Y GESTODENE. ASIMISMO, I) Y II) COMPRENDEN 14 UNIDADES DE DOSIFICACION DIARIAS. CON ESTE REGIMEN SE OBTIENE UN BUEN CONTROL DEL CICLO Y EFICACIA ANTICONCEPTIVAIT REFERS TO A CONTRACEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF PROGESTAGEN, CHARACTERIZED BY BEING DIVIDED INTO TWO PHASES: I) DAILY ADMINISTRATION OF 10 TO 20 DAYS OF A PROGESTAGEN IN AN AMOUNT OF THE LOWEST POSSIBLE; AND, II) DAILY ADMINISTRATION FOR AT LEAST 7 DAYS OF A PROGESTAGEN IN AN AMOUNT THAT IS AT LEAST DOUBLE OF PHASE I), BUT NOT LOWER THAN THE DOSE REQUIRED TO CAUSE THE TRANSFORMATION OF THE ENDOMETRIUM. WHERE THE PROGESTAGEN IS SELECTED FROM THE GROUP CONSISTING OF DESOGESTREL, ORG 30659, LEVONORGESTREL AND GESTODENE. ALSO, I) AND II) INCLUDE 14 DAILY DOSAGE UNITS. WITH THIS REGIME, GOOD CYCLE CONTROL AND CONTRACEPTIVE EFFECTIVENESS IS OBTAINED

PE1999000799A 1998-08-11 1999-08-09 "PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROL PE20000887A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98202699 1998-08-11

Publications (1)

Publication Number Publication Date
PE20000887A1 true PE20000887A1 (en) 2000-09-15

Family

ID=8234025

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000799A PE20000887A1 (en) 1998-08-11 1999-08-09 "PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROL

Country Status (3)

Country Link
AU (1) AU5619399A (en)
PE (1) PE20000887A1 (en)
WO (1) WO2000009136A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2745541C (en) * 2008-12-12 2016-11-08 Laboratoire Hra-Pharma A method for contraception
BRPI1014035A2 (en) 2009-04-14 2016-04-12 Hra Pharma Lab method for contraception.
EP2730284A1 (en) * 2012-11-12 2014-05-14 Naari AG Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation
US11679114B2 (en) * 2021-07-26 2023-06-20 Navad Life Sciences Pte Progestogen-only oral contraception

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066757A (en) * 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel

Also Published As

Publication number Publication date
AU5619399A (en) 2000-03-06
WO2000009136A1 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
PE20060485A1 (en) CONTRACEPTIVE REGIMES WITH PROGESTERONE RECEPTOR ANTAGONISTS AND KITS
AR046671A1 (en) EXTENDED USE OF COMBINATION THAT INCLUDES STROGENS AND PROGESTINES
CA2468748A1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
BR9916579A (en) Three-phase oral contraceptive
ES2116804T3 (en) POLYPHASIC PREPARATION FOR CONTRACEPTION BASED ON NATURAL ESTROGENS.
ES2158988T3 (en) AEROSOL COMPOSITIONS.
BR9813262A (en) Progestin therapy with controlled bleeding
NO986104L (en) Progesterone-anti-progesterone regimens
KR920011514A (en) Contraceptives containing only progestogens
AR049112A1 (en) COMPOSITIONS, METHODS AND KIT, FOR THE TREATMENT OF PREMENSTRUAL DYSPHORIC DISORDER
ES2348038T5 (en) Polyphasic preparation for contraception based on a natural estrogen
NO20061937L (en) Extended three-phase prevention course
PE20000887A1 (en) "PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROL
PE20031047A1 (en) TREATMENT OF POST-MENOPAUSAL PATIENTS IN PATIENTS WITH BREAST CANCER
KR920019350A (en) Pharmaceutical Compositions for Autoimmune Disease Therapy
ES2105923B1 (en) COMPOSITIONS FOR THE TREATMENT OF AN INFECTION AND DISEASE CAUSED BY THE HEPATITIS B (HBV) VIRUS.
PE20070555A1 (en) USE OF ESTRADIOL VALERATE IN COMBINATION WITH DIENOGEST FOR THE ORAL THERAPY OF DYSFUNCTIONAL UTERINE HEMORRHAGE CONNECTED WITH AN ORAL CONTRACEPTION
KR900011461A (en) Therapeutics using trypstatin as an active ingredient
NZ504351A (en) Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen
RS50283B (en) Mesoprogestins for the treatment and prevention of benign gynecological disorders
UY26966A1 (en) USE OF ANTIPROGESTINES FOR THE INDUCTION OF APOPTOSIS IN A CELL
ECSP993091A (en) CONTRACEPTIVE REGIME OF THE "PROGESTAGEN ONLY" TYPE WHICH ALLOWS A GOOD CONTROL OF THE CYCLE AND CONTRACEPTIVE EFFECTIVENESS, WHERE THE PROGESTAGEN IS SUPPLIED IN TWO PHASES
KR960700726A (en) METHOD OF PREVENTING OF INHIBTING FERTILIZATION
KR910004190A (en) New medical uses of ondansetron
KR960701642A (en) METHOD AND COMPOSITION FOR TREATMENT OF OSTEOPOROSIS

Legal Events

Date Code Title Description
FC Refusal